PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of plosonePLoS OneView this ArticleSubmit to PLoSGet E-mail AlertsContact UsPublic Library of Science (PLoS)
 
PLoS One. 2011; 6(5): e20649.
Published online May 31, 2011. doi:  10.1371/journal.pone.0020649
PMCID: PMC3105107

Genes of the Unfolded Protein Response Pathway Harbor Risk Alleles for Primary Open Angle Glaucoma

Amanda Ewart Toland, Editor

Abstract

The statistical power of genome-wide association (GWA) studies to detect risk alleles for human diseases is limited by the unfavorable ratio of SNPs to study subjects. This multiple testing problem can be surmounted with very large population sizes when common alleles of large effects give rise to disease status. However, GWA approaches fall short when many rare alleles may give rise to a common disease, or when the number of subjects that can be recruited is limited. Here, we demonstrate that this multiple testing problem can be overcome by a comparative genomics approach in which an initial genome-wide screen in a genetically amenable model organism is used to identify human orthologues that may harbor risk alleles for adult-onset primary open angle glaucoma (POAG). Glaucoma is a major cause of blindness, which affects over 60 million people worldwide. Several genes have been associated with juvenile onset glaucoma, but genetic factors that predispose to adult onset primary open angle glaucoma (POAG) remain largely unknown. Previous genome-wide analysis in a Drosophila ocular hypertension model identified transcripts with altered regulation and showed induction of the unfolded protein response (UPR) upon overexpression of transgenic human glaucoma-associated myocilin (MYOC). We selected 16 orthologous genes with 62 polymorphic markers and identified in two independent human populations two genes of the UPR that harbor POAG risk alleles, BIRC6 and PDIA5. Thus, effectiveness of the UPR in response to accumulation of misfolded or aggregated proteins may contribute to the pathogenesis of POAG and provide targets for early therapeutic intervention.

Introduction

POAG is the most prevalent form of glaucoma, and a major cause of irreversible blindness [1]. It is a complex inherited disorder that affects over 2 million people in the United States and is estimated to afflict over 60 million people worldwide [2]. POAG is often, but not always, accompanied by ocular hypertension and characterized by progressive loss of retinal ganglion cells, atrophy of the optic nerve, and visual field loss [3], [4]. Over 20 genetic loci and mutations in four genes have been associated with some cases of POAG, including CYP1B1, MYOC (myocilin), OPTN (optineurin) and WDR36, but the molecular pathogenesis of the disease remains largely unknown [5], [6], [7]. To date, there have been two POAG genome-wide association (GWA) studies [8], [9]. The first has identified intergenic polymorphic markers associated with POAG in a Japanese population, but these markers could not be linked to annotated genes [8], while another GWA study has implicated a common variant near CAV1 and CAV2 in POAG [9]. It is not uncommon for different GWA studies to discover different marker associations for the same phenotype. Replication can be predicted only when the assumption that common alleles underlie a common disease is valid. However, when disease status represents a large mutational target, i.e. many rare alleles can predispose to the same disease phenotype, it is unlikely that different populations capture the same low frequency alleles, and populations of different genetic backgrounds may harbor population-specific variants.

To address the challenging multiple testing problem inherent in GWA studies and to identify potential candidate genes involved in POAG pathogenesis, we explored a comparative genomics strategy. We developed a transgenic Drosophila model to analyze whole-genome transcription profiles from heads of flies that express human MYOC in their eyes. Overexpression of MYOC results in distortion of the ommatidia, accompanied by periodic fluid discharge through the lenses [10], [11]. Western blotting identified the accumulation of myocilin aggregates and a genetically expressed fluorescent indicator revealed activation of the UPR [10], [11]. Although the anatomy and physiology of the fly eye is different from the human eye [12], we reasoned that stress pathways, such as the unfolded protein response (UPR) [13], would be evolutionarily conserved and that human orthologues of genes that undergo altered regulation in the Drosophila ocular hypertension model could be identified as candidate genes that might harbor risk alleles for POAG in human populations. Based on results from the previous study in the Drosophila MYOC-induced ocular hypertension model [11], we selected genes based on three criteria (Table S1): (1) they showed differential expression on Drosophila microarrays (FDR<0.005) [11]; (2) they have human orthologs; and (3) they have known functions in the UPR, ubiquitination, proteolysis, or oxidative-stress pathways [14], [15], [16]. We also included MYOC [17], OPTN [18], and NTE [10], because these genes had previously been implicated in glaucoma. We employed a case-control study using two different Caucasian populations (Salt Lake City, Utah and San Diego, California). We identified several SNPs significantly associated with POAG and two of these (rs2754511 and rs11720822) were identified in both of our study populations, implicating UPR in the pathogenesis of POAG.

Results

Statistical Analysis of SNP Associations with POAG

Mutations in MYOC have been associated with juvenile onset glaucoma, and with some cases of POAG [17], [19]. OPTN has also been associated with various forms of glaucoma, including POAG and normal tension glaucoma [20]. We did not detect associations between MYOC with POAG in either the Salt Lake City or San Diego population. This is perhaps not surprising as MYOC mutations have been associated with only ~3–4% of POAG cases [7]. We did, however, find an association between OPTN and POAG in the Salt Lake City population (rs10906308, P = 5.84×10–9; Figure 1 and Table S2). The same SNP in the San Diego population, however, does not reach statistical significance (P = 0.04). Similarly, SNPs in CYP1B1 and PSMB7, which encodes proteasome subunit beta 7, are significantly associated with POAG in the Salt Lake City population only (Figure 1 and Table S2). Thus, previously reported associations with POAG of at least some candidate genes were replicated in at least one of our populations.

Figure 1
Association between POAG and candidate gene tagging rsSNPs.

We identified SNPs associated with POAG in both the Salt Lake City and San Diego populations in PDIA5 (PDIR), a protein disulfide isomerase which facilitates the formation of disulfide bonds during protein folding and is associated with the UPR (Tables S3 and S4), and in BIRC6 (BRUCE, APOLLON), which encodes a ubiquitin ligase that protects against apoptosis (Tables S5 and S6) [21], [22]. In PDIA5, rs11720822 is significantly associated with POAG in both the Salt Lake City and San Diego populations (Tables S3 and S4). Additional SNPs in PDIA5 are significantly associated with POAG in only one of the populations; rs2241962 and rs2667465 are significant in the Salt Lake City population only (Tables S2 and S3).

Haplotype Analysis

We next examined linkage disequilibrium (LD) among the 8 PDIA5 SNPs (rs11720822, rs2241962, rs2667465, rs3792361, rs3792390, rs4677994, rs702029, rs836833) and among the 5 BIRC6 SNPs (rs12612824, rs17820747, rs2069213, rs2254106, and rs2754511) that were genotyped in both cohorts. Patterns of LD are similar among the SNPs for both PDIA5 and BIRC6 in both populations and between cases and controls (Figures S1 and S2).

We next compared the distributions of the haplotypes composed of these PDIA5 and BIRC6 SNPs (Figure 2, Tables S7, S8, S9, S10). The frequency of the GTAAAGGG haplotype of PDIA5 was higher in POAG cases than controls in both the Salt Lake City and San Diego populations (odds ratio = 2.4 (95% CI 1.6–3.5) in the Salt Lake City population; odds ratio = 6.0 (95% CI 2.4–16.3) for the San Diego population; Tables S7 and S8), implicating it as a risk haplotype in both populations. In addition to SNPs in PDIA5, we identified one SNP in BIRC6, rs2754511, that was significantly associated with POAG in both the Salt Lake City (P = 1.6×10−8) and San Diego population (P = 7.5×10−4) (Figure 1 and Table S2). Haplotype analysis indicates that the GAAAT haplotype of BIRC6 appears to be protective in each population (Tables S9 and S10).

Figure 2
Association of PDIA5 (A) and BIRC6 (B) haplotypes with POAG.

All POAG-associated SNPs are in introns, except rs12612824, which tags BIRC6 in an intergenic region. Sequence variants in non-coding gene regions may affect transcription efficiency, alternative splicing and/or mRNA stability. Large LD blocks in the human genome, however, make it difficult to identify not only causal SNPs, but, depending on the extent of linkage disequilibrium, also causal genes. However, identification of risk alleles in genes located on different chromosomes that contribute to a common cellular pathway instills confidence that PDIA5 and BIRC6 are likely to be indeed causally associated with POAG risk.

Discussion

Previous GWA studies on glaucoma identified intergenic SNPs [8] and implicated a common variant near CAV1 and CAV2 in POAG [9] but failed to identify genes previously associated with glaucoma, such as MYOC and OPTN [6], [7]. Although these studies used large numbers of unaffected controls, the actual number of POAG cases was restricted to 418 and 1263, respectively. This limitation combined with the large number of SNPs surveyed may have limited the detection power of these studies. We have circumvented the large multiple testing problem inherent in GWA studies by using a comparative genomic approach that enabled us to perform a genome-wide transcriptional analysis in Drosophila [11] and to select, based on the results of these studies, 16 evolutionarily conserved candidate genes with human orthologs. Thus, whereas a previous GWA study surveyed 303,117 SNPs across the genome with about three times more POAG samples than our study [9], we interrogated about 5,000 times fewer polymorphic markers, thereby gaining substantial power for identifying alleles significantly associated with POAG.

We genotyped 62 SNPs in a Salt Lake City population and in a San Diego replicate population and identified two SNPs associated with POAG in both populations. We also observed SNPs in OPTN, CYP1B1 and PSMB7 associated with POAG, but only in the Salt Lake City population. This observation supports the general notion that different populations may harbor distinct risk alleles for the same disease.

The two SNPs significantly associated with POAG in both populations are in two different genes, BIRC6 and PDIA5, both of which function to reduce endoplasmic reticulum (ER) stress. BIRC6 is an ubiquitin-carrier protein involved in the regulation of apoptosis [22], while PDIA5 is an ER chaperone that is induced during ER stress [23]. The identification of two alleles which both function to alleviate ER stress, strongly implicates the UPR as a pathogenic mechanism for POAG in these populations. Studies in tissue culture [24] and mice [25] have also indicated that sequestration of myocilin in the ER may be associated with POAG. Furthermore, misfolded mutant myocilin forms intracellular aggregates that fail to be transported from the ER to the cytosol; as a result, components of the UPR, including BiP and PERK are induced, with subsequent apoptotic cell death [16]. One can speculate that apoptotic cell death in the trabecular meshwork would impair the ability of the anterior chamber to regulate intraocular pressure and lead to POAG resulting from ocular hypertension, whereas apoptotic cell death resulting from failure of the UPR in retinal ganglion cells themselves could conceivably be a contributing factor to normal tension glaucoma.

Components of the UPR have been associated with several common neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease [26], [27]. Association of PDIA5 and BIRC6 (as well as PSMB7 and CYP1B1 in the Salt Lake City population) with POAG indicates that adult-onset glaucoma belongs to the same category of late onset neurodegenerative diseases. Previous studies in trabecular meshwork cell cultures and the Drosophila ocular hypertension model have also been suggestive of the UPR in the pathology of glaucoma [11], [14], [28]. Our results indicate that DNA variants that compromise the efficiency of the UPR may give rise to a common mechanism for the pathogenesis of POAG, and implicate the UPR as a future target for therapeutic intervention.

Materials and Methods

Study Population

This study was approved by the Institutional Review Boards of the University of California San Diego and the University of Utah. All participants provided written informed consent prior to participation in the study and are of Caucasian ethnicity. POAG diagnosis was made by the presence of specific signs of glaucomatous optic nerve damage on an eye examination plus visual field defects; intraocular pressure (IOP) was not considered in this definition. The normal controls were from the same geographic areas with a healthy optic nerve and cup to disc ratio <0.3. None of the control individuals had elevated IOP. The mean ages of our San Diego cohorts for controls and cases were 69 and 76, respectively. The mean ages of our Salt Lake City cohorts for controls and cases were 68 and 74, respectively. Males and females were evenly distributed among the sample sets. DNA was extracted from blood samples by using the FlexiGene DNA kit (Qiagen) for genotype analyses.

SNP Selection and Genotyping

Based on results from a previous study in the Drosophila MYOC-induced ocular hypertension model [11], we selected 16 candidate genes, which were homologs of differentially expressed genes (FDR<0.005) in the Drosophila model and play a role in the UPR, ubiquitination, proteolysis, or oxidative-stress pathways (Table S1). Tagging SNPs were chosen from genotyped SNPs of Utah residents with ancestry from Northern and Western Europe (CEU) in the HapMap (www.hapmap.org) and NCBI dbSNP (http://www.ncbi.nlm.nih.gov/SNP/) databases (minor allele frequency ≥0.05) using Tagger software [29]. We genotyped 207 POAG cases and 270 normal controls in the population from Salt Lake City, Utah. For the replicate population from San Diego, California, we genotyped 471 POAG cases and 151 normal controls. To avoid spurious associations due to population admixture, we restricted our cohorts exclusively to subjects of Caucasian ethnicity. Genotyping was performed with an Illumina GoldenGate Oligo Pool All (OPA) assay, which is based on hybridization of allele-specific oligonucleotides (Table S1) to biotinylated DNA immobilized to streptavidin-coated paramagnetic particles. The allelic variant that matches the genomic sequence is preferentially extended to produce a synthetic template which is then amplified with fluorescently labeled universal primers and hybridized to VeraCode beads through an address sequence [30][32].

Genotype calling was performed using BeadStudio Version 3 (Illumina, Inc.). The accuracy of the genotype calls was manually evaluated using the software's clustering algorithm and quality scores. Following removal of genotypes with low quality scores, the genotyping error rate was estimated to be 1.4%.

Statistical Analysis

To test the 62 SNPs for associations with disease status, we computed the likelihood ratio chi-square (χ2) for each SNP, by population, using JMP 8 (Table S2). We used a conservative Bonferroni corrected P-value of 0.0008 as the threshold. HWE tests, allele frequencies, genotype frequencies, LD (D' and r2), and haplotype analyses were performed using the online software SHEsis (http://analysis.bio-x.cn/myAnalysis.php) [33], [34].

Supporting Information

Figure S1

Linkage disequilibrium (D') among 8 rsSNPs in the PDIA5 gene. Controls (A and C) and POAG (B and D) for both the Salt Lake City (A and B) and San Diego (C and D) populations are shown. Linkage disequilibrium analyses (D' and r2) were performed using the online software, SHEsis (http://analysis.bio-x.cn/myAnalysis.php) (31, 32). The D' values are highlighted as follows: red (1.0<D'<0.75); dark pink (0.74<D'<0.65); light pink (0.64<D'<0.10) and white (0.09<D'<0).

(TIF)

Figure S2

Linkage disequilibrium (D') among 5 rsSNPs in the BIRC6 gene. Controls (A and C) and POAG (B and D) for both the Salt Lake City (A and B) and San Diego (C and D) populations are shown. Linkage disequilibrium analyses (D' and r2) were performed using the online software, SHEsis (http://analysis.bio-x.cn/myAnalysis.php) (31, 32). The D' values are highlighted as follows: red (1.0<D'<0.75); dark pink (0.74<D'<0.65); light pink (0.64<D'<0.10) and white (0.09<D'<0).

(TIF)

Table S1

Sequences of rsSNPs genotyped in the Salt Lake City and San Diego cohorts.

(DOC)

Table S2

Associations of SNPs with POAG in the Salt Lake City and San Diego cohorts.

(DOC)

Table S3

χ2 tests for frequency distributions of alleles and genotypes in PDIA5 (Salt Lake City, Utah).

(DOC)

Table S4

χ2 tests for frequency distributions of alleles and genotypes in PDIA5 (San Diego, California).

(DOC)

Table S5

χ2 tests for frequency distributions of alleles and genotypes in BIRC6 (Salt Lake City, Utah).

(DOC)

Table S6

χ2 tests for frequency distributions of alleles and genotypes in BIRC6 (San Diego, California).

(DOC)

Table S7

Estimated PDIA5 haplotype frequencies and association significance for the Salt Lake City population.

(DOC)

Table S8

Estimated PDIA5 haplotype frequencies and association significance for the San Diego population.

(DOC)

Table S9

Estimated BIRC6 haplotype frequencies and association significance for the Salt Lake City population.

(DOC)

Table S10

Estimated BIRC6 haplotype frequencies and association significance for the San Diego population.

(DOC)

Acknowledgments

We thank Dahlia Nielsen and Alison Motsinger-Reif for helpful discussions, and Maureen Crocker, Seanna Grob, and Brad Williams for patient recruitment, clinical information collection and DNA extraction.

Footnotes

Competing Interests: The authors have declared that no competing interests exist.

Funding: This work was supported by grants from the National Institutes of Health (EY015873 to RRHA; EY018660, EY019270, EY014428, EY021374 to KZ), Research to Prevent Blindness, Chinese National 985 Project to Sichuan University and West China Hospital (KZ), and a Burroughs Wellcome Fund Clinical Scientist Award in Translational Research (KZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

1. Julvez LP, Del Castillo Sanchez JB, Feijoo JG, Rubio-Terres C. Methodologic quality of studies on prognostic factors for primary open-angle glaucoma progression measured by visual field deterioration. J Glaucoma. 2010;19:587–591. [PubMed]
2. Quigley HA, Broman AT. The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol. 2006;90:262–267. [PMC free article] [PubMed]
3. Sharts-Hopko NC, Glynn-Milley C. Primary open-angle glaucoma. Am J Nurs. 2009;109:40–47. [PubMed]
4. Mozaffarieh M, Grieshaber MC, Flammer J. Oxygen and blood flow: Players in the pathogenesis of glaucoma. Mol Vis. 2008;14:224–233. [PMC free article] [PubMed]
5. Kumar A, Basavaraj MG, Gupta SK, Qamar I, Ali AM, et al. Role of CYP1B1, MYOC, OPTN, and OPTC genes in adult-onset primary open-angle glaucoma: Predominance of CYP1B1 mutations in Indian patients. Mol Vis. 2007;13:667–676. [PMC free article] [PubMed]
6. Allingham RR, Liu Y, Rhee DJ. The genetics of primary open-angle glaucoma: A review. Exp Eye Res. 2009;88:837–844. [PubMed]
7. Fan BJ, Wang DY, Lam DS, Pang CP. Gene mapping for primary open angle glaucoma. Clin Biochem. 2006;39:249–258. [PubMed]
8. Nakano M, Ikeda Y, Taniguchi T, Yagi T, Fuwa M, et al. Three susceptible loci associated with primary open-angle glaucoma identified by genome-wide association study in a Japanese population. Proc Natl Acad Sci U S A. 2009;106:12838–12842. [PubMed]
9. Thorleifsson G, Walters GB, Hewitt AW, Masson G, Helgason A, et al. Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma. Nat Genet. 2010;42:906–909. [PMC free article] [PubMed]
10. Borras T, Morozova TV, Heinsohn SL, Lyman RF, Mackay TF, et al. Transcription profiling in Drosophila eyes that overexpress the human glaucoma-associated trabecular meshwork-inducible glucocorticoid response protein/myocilin (TIGR/MYOC). Genetics. 2003;163:637–645. [PubMed]
11. Carbone MA, Ayroles JF, Yamamoto A, Morozova TV, West SA, et al. Overexpression of myocilin in the Drosophila eye activates the unfolded protein response: Implications for glaucoma. PLoS One. 2009;4:e4216. [PMC free article] [PubMed]
12. Borst A. Drosophila's view on insect vision. Curr Biol. 2009;19:R36–47. [PubMed]
13. Zhang K. Integration of ER stress, oxidative stress and the inflammatory response in health and disease. Int J Clin Exp Med. 2010;3:33–40. [PMC free article] [PubMed]
14. Joe MK, Sohn S, Hur W, Moon Y, Choi YR, et al. Accumulation of mutant myocilins in ER leads to ER stress and potential cytotoxicity in human trabecular meshwork cells. Biochem Biophys Res Commun. 2003;312:592–600. [PubMed]
15. Liu Y, Vollrath D. Reversal of mutant myocilin non-secretion and cell killing: Implications for glaucoma. Hum Mol Genet. 2004;13:1193–1204. [PubMed]
16. Yam GH, Gaplovska-Kysela K, Zuber C, Roth J. Aggregated myocilin induces russell bodies and causes apoptosis: Implications for the pathogenesis of myocilin-caused primary open-angle glaucoma. Am J Pathol. 2007;170:100–109. [PubMed]
17. Stone EM, Fingert JH, Alward WL, Nguyen TD, Polansky JR, et al. Identification of a gene that causes primary open angle glaucoma. Science. 1997;275:668–670. [PubMed]
18. Rezaie T, Child A, Hitchings R, Brice G, Miller L, et al. Adult-onset primary open-angle glaucoma caused by mutations in optineurin. Science. 2002;295:1077–1079. [PubMed]
19. Johnson DH. Myocilin and glaucoma: A TIGR by the tail? Arch Ophthalmol. 2000;118:974–978. [PubMed]
20. Chalasani ML, Swarup G, Balasubramanian D. Optineurin and its mutants: Molecules associated with some forms of glaucoma. Ophthalmic Res. 2009;42:176–184. [PubMed]
21. Maattanen P, Gehring K, Bergeron JJ, Thomas DY. Protein quality control in the ER: The recognition of misfolded proteins. Semin Cell Dev Biol. 2010;21:500–511. [PubMed]
22. Liu CH, Goldberg AL, Qiu XB. New insights into the role of the ubiquitin-proteasome pathway in the regulation of apoptosis. Chang Gung Med J. 2007;30:469–479. [PubMed]
23. Ni M, Lee AS. ER chaperones in mammalian development and human diseases. FEBS Lett. 2007;581:3641–3651. [PMC free article] [PubMed]
24. Gobeil S, Rodrigue MA, Moisan S, Nguyen TD, Polansky JR, et al. Intracellular sequestration of hetero-oligomers formed by wild-type and glaucoma-causing myocilin mutants. Invest Ophthalmol Vis Sci. 2004;45:3560–3567. [PubMed]
25. Kim BS, Savinova OV, Reedy MV, Martin J, Lun Y, et al. Targeted disruption of the myocilin gene (MYOC) suggests that human glaucoma-causing mutations are gain of function. Mol Cell Biol. 2001;21:7707–7713. [PMC free article] [PubMed]
26. Salminen A, Kauppinen A, Suuronen T, Kaarniranta K, Ojala J. ER stress in Alzheimer's disease: A novel neuronal trigger for inflammation and Alzheimer's pathology. J Neuroinflammation. 2009;6:41. [PMC free article] [PubMed]
27. Hosoi T, Ozawa K. Endoplasmic reticulum stress in disease: Mechanisms and therapeutic opportunities. Clin Sci (Lond) 2010;118:19–29. [PubMed]
28. Wang L, Zhuo Y, Liu B, Huang S, Hou F, et al. Pro370Leu mutant myocilin disturbs the endoplasm reticulum stress response and mitochondrial membrane potential in human trabecular meshwork cells. Mol Vis. 2007;13:618–625. [PMC free article] [PubMed]
29. de Bakker PI, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, et al. Efficiency and power in genetic association studies. Nat Genet. 2005;37:1217–1223. [PubMed]
30. Fan JB, Gunderson KL, Bibikova M, Yeakley JM, Chen J, et al. Illumina universal bead arrays. Methods Enzymol. 2006;410:57–73. [PubMed]
31. Fan JB, Oliphant A, Shen R, Kermani BG, Garcia F, et al. Highly parallel SNP genotyping. Cold Spring Harb Symp Quant Biol. 2003;68:69–78. [PubMed]
32. Lin CH, Yeakley JM, McDaniel TK, Shen R. Medium- to high-throughput snp genotyping using VeraCode microbeads. Methods Mol Biol. 2009;496:129–142. [PubMed]
33. Li Z, Zhang Z, He Z, Tang W, Li T, et al. A partition-ligation-combination-subdivision EM algorithm for haplotype inference with multiallelic markers: Update of the SHEsis. Cell Res. 2009;19:519–523. ( http://analysis.Bio-x.Cn) [PubMed]
34. Shi YY, He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res. 2005;15:97–98. [PubMed]

Articles from PLoS ONE are provided here courtesy of Public Library of Science